GlaxoSmithKline PLC News Headlines

GSK 
$48.47
*  
0.44
0.92%
Get GSK Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading GSK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Actavis Joins the Divestment Bandwagon - Analyst Blog
1/20/2014 6:55:01 PM - Zacks.com

Great Dividend Growth Stocks From United Kingdom
1/20/2014 10:17:00 AM - Seeking Alpha

China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies
1/19/2014 2:07:00 AM - Seeking Alpha

Amicus Update on Strategy, Guidance - Analyst Blog
1/17/2014 6:49:01 PM - Zacks.com

Carlyle Group Offers to Buy JNJ's OCD Biz - Analyst Blog
1/17/2014 6:00:01 PM - Zacks.com

AstraZeneca: Should You Buy This 4.5% Yielder?
1/16/2014 11:56:00 AM - Seeking Alpha

Update on Glaxo's Oncology Pipeline - Analyst Blog
1/13/2014 1:20:01 PM - Zacks.com

Bluebird Bio: 5 Different Insiders Have Sold Shares During The Last 30 Days
1/13/2014 12:31:00 PM - Seeking Alpha

AstraZeneca's Farxiga Gets FDA Nod - Analyst Blog
1/9/2014 6:00:01 PM - Zacks.com

Eli Lilly Shares down Slightly on Guidance - Analyst Blog
1/9/2014 2:40:01 PM - Zacks.com

Epizyme Up on Milestone Payments - Analyst Blog
1/8/2014 1:10:01 PM - Zacks.com

Pharmacyclics Soars on Positive Imbruvica News - Analyst Blog
1/8/2014 12:40:01 PM - Zacks.com

Pick GlaxoSmithKline For A Sustainable 4.6% Yield
1/7/2014 6:50:00 PM - Seeking Alpha

Exelixis Has A Stellar Year Ahead
1/6/2014 5:21:00 PM - Seeking Alpha

Amicus Therapeutics Raises Funds - Analyst Blog
1/2/2014 5:55:01 PM - Zacks.com

Glaxo Divests Certain Assets - Analyst Blog
1/2/2014 1:50:01 PM - Zacks.com

Which ADRs Are The Most Widely Held?
1/2/2014 5:17:00 AM - Seeking Alpha

Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
12/25/2013 7:57:00 AM - Seeking Alpha

Update on Glaxo's HIV Drugs - Analyst Blog
12/24/2013 5:17:27 PM - Zacks.com

My High Share Buyback And Dividend Growth Portfolio 4th Quarter 2013 Review
12/24/2013 10:18:00 AM - Seeking Alpha

Cervical Cancer Should Not Be Ignored By Biotech Investors
12/24/2013 9:59:00 AM - Seeking Alpha

Pre-Market Most Active for Dec 24, 2013 : SRC, FB, MDLZ, ARIA, UN, SUPN, TWTR, BAC, GSK, ALU, DRYS, TSLA
12/24/2013 9:38:54 AM - NASDAQ.com News

Glaxo's Two-Dose Cervarix Cleared in EU - Analyst Blog
12/23/2013 6:10:01 PM - Zacks.com

Gilead Sciences And The Numbers Game
12/23/2013 9:51:00 AM - Seeking Alpha

China Biotech Week In Review: Simcere Pharma Going Private
12/22/2013 4:25:00 AM - Seeking Alpha